Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nathalie Roxanne Javidi-Sharifi, M.D., Ph.D.

Concepts (69)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Chronic-Phase12021370.770 Why?
Fibroblast Growth Factor 2320195900.680 Why?
Protein Kinase Inhibitors6202456290.640 Why?
Receptor, Fibroblast Growth Factor, Type 1120192560.590 Why?
Pyrazoles2202419900.540 Why?
Piperidines1202416390.510 Why?
Receptor, Fibroblast Growth Factor, Type 3220141050.490 Why?
Proto-Oncogene Proteins c-kit220187260.480 Why?
Exosomes120194230.460 Why?
Pyrimidines3202430060.460 Why?
Leukemia, Lymphocytic, Chronic, B-Cell1202416270.420 Why?
Gastrointestinal Stromal Tumors220186150.420 Why?
Mesenchymal Stem Cells1201916340.300 Why?
Leukemia, Myeloid, Acute2201935990.260 Why?
Antineoplastic Agents32024135910.210 Why?
Antineoplastic Combined Chemotherapy Protocols12021117090.180 Why?
Niacinamide120214140.170 Why?
Adenine120249750.160 Why?
Signal Transduction32023233410.140 Why?
Drug Resistance, Neoplasm4201852480.140 Why?
GTP-Binding Protein beta Subunits12014330.120 Why?
Receptor Cross-Talk120141160.120 Why?
Sulfonamides1202419730.120 Why?
Phosphatidylinositol 3-Kinases1202328580.110 Why?
Drug Discovery1202110440.110 Why?
fms-Like Tyrosine Kinase 3120164950.110 Why?
Immunoprecipitation120148770.100 Why?
Pyridazines120142000.100 Why?
Benzamides2201413680.100 Why?
Protein Interaction Domains and Motifs120144520.100 Why?
Drug Synergism1201417450.090 Why?
GTP-Binding Proteins120149500.090 Why?
Gene Knockdown Techniques1201416100.090 Why?
RNA, Small Interfering2201834330.080 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive120146850.080 Why?
Cell Survival1201957810.080 Why?
Cell Line, Tumor52018168860.080 Why?
Clinical Trials as Topic1202479850.080 Why?
Lymphoma, B-Cell120149350.080 Why?
Imidazoles1201411790.070 Why?
MAP Kinase Signaling System1201414770.070 Why?
Piperazines2201425110.070 Why?
HEK293 Cells1201442580.060 Why?
Cell Transformation, Neoplastic1201428250.060 Why?
Mice, Knockout12019143540.060 Why?
Phosphorylation1201482970.060 Why?
Mutation42018299150.050 Why?
Cells, Cultured12019189420.050 Why?
Membrane Proteins1201878430.050 Why?
Proto-Oncogene Proteins c-akt2202324430.050 Why?
Melanoma1201856910.040 Why?
Disease Models, Animal12019181250.040 Why?
Humans920247583810.040 Why?
Treatment Outcome12024643790.040 Why?
Mice32019811070.030 Why?
Neoplasms12023220300.030 Why?
TOR Serine-Threonine Kinases1202320570.030 Why?
Proto-Oncogene Proteins c-raf120142020.030 Why?
Proto-Oncogene Proteins c-abl120141400.030 Why?
Fusion Proteins, bcr-abl120144310.030 Why?
Tumor Microenvironment2201638400.030 Why?
K562 Cells120146390.030 Why?
Animals320191677770.020 Why?
Janus Kinase 2120145370.020 Why?
Xenograft Model Antitumor Assays1201835740.020 Why?
Adult120242199160.020 Why?
Mitogen-Activated Protein Kinases1201412450.020 Why?
Proto-Oncogene Proteins p21(ras)1201417250.020 Why?
Gene Expression Regulation, Neoplastic1201485060.010 Why?
Javidi-Sharifi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.